58.55
27-11月-24 15:45:00
15 分の遅延
株式
+1.16
+2.02%
本日の幅
56.78 - 58.81
ISIN
N/A
ソース
NASDAQ
Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference
05 3 2021 07:00:00 提供 Nasdaq GlobeNewswire
Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference
02 3 2021 07:00:02 提供 Nasdaq GlobeNewswire
Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
17 2 2021 07:00:01 提供 Nasdaq GlobeNewswire